메뉴 건너뛰기




Volumn 8, Issue 4, 2003, Pages 289-290

Quantifying effects of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: Systematic review and meta-analysis

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; CERIVASTATIN; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEVINOLIN; PLACEBO; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

EID: 2342615606     PISSN: 1358863X     EISSN: None     Source Type: Journal    
DOI: 10.1191/1358863x03vm518xx     Document Type: Review
Times cited : (14)

References (5)
  • 1
    • 0037490080 scopus 로고    scopus 로고
    • Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: Systematic review and meta-analysis
    • Law MR, Wald NJ, Rudnicka AR. Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis. BMJ 2003; 326: 1407-408.
    • (2003) BMJ , vol.326 , pp. 1407-1408
    • Law, M.R.1    Wald, N.J.2    Rudnicka, A.R.3
  • 2
    • 0242285687 scopus 로고    scopus 로고
    • The statin wars: Why AstraZeneca must retreat
    • The statin wars: why AstraZeneca must retreat. Lancet 2003; 362: 1341.
    • (2003) Lancet , vol.362 , pp. 1341
  • 3
    • 0011933958 scopus 로고    scopus 로고
    • Controversy surrounding the safety of cerivastatin
    • Davidson MH. Controversy surrounding the safety of cerivastatin. Expert Opin Drug Saf 2002; 1: 207-12.
    • (2002) Expert Opin. Drug Saf. , vol.1 , pp. 207-212
    • Davidson, M.H.1
  • 4
    • 0942300658 scopus 로고    scopus 로고
    • Rosuvastatin-warfarin drug interaction
    • Barry M. Rosuvastatin-warfarin drug interaction. Lancet 2004; 363: 328.
    • (2004) Lancet , vol.363 , pp. 328
    • Barry, M.1
  • 5
    • 0037031061 scopus 로고    scopus 로고
    • MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: A randomized placebo-controlled trial
    • Heart Protection Study Collaborative Group
    • Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomized placebo-controlled trial. Lancet 2002; 360: 7-22.
    • (2002) Lancet , vol.360 , pp. 7-22


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.